NICE CVD guideline

Heart in NICE Orange

A concise summary of NICE's evidence-based clinical guideline on lipid modification for the prevention of cardiovascular disease.

Cardiovascular disease (CVD) refers to atherosclerosis affecting the heart and blood vessels and includes ischaemic heart disease and stroke. It is the leading cause of death in England and Wales and accounts for almost one-third of deaths. CVD risk factors include non‑modifiable factors of age, sex, family history of CVD and ethnic background, and modifiable risk factors of smoking, raised blood pressure and cholesterol. Management of CVD involves addressing modifiable risk factors and the use of pharmacological agents, particularly lipid-lowering agents. Identification of people at risk of cardiovascular disease and primary prevention strategies are important roles for primary care.

This Guidelines for Nurses summary provides recommendations on when to undertake a risk assessment for CVD, how to communicate CVD risk to patients, lifestyle modifications for risk reduction, and the use of statins in primary and secondary prevention.

Register or subscribe to view this content

Please sign in to continue reading this content, or …

Register for FREE

Guidelines for Nurses is free for UK-based doctors, nurses, and pharmacists.

Sign-up now—it takes just a few minutes and you’ll get unlimited access to all of our content, including summaries, expert articles, tools and resources, and CPD modules.

Or read for £5

Pay £5.00 to continue reading this content.

This will entitle you to unlimited access to our summaries, expert articles, and CPD modules for 30 days.